Evidence map›Paper›PMID 40969726›Full record

Trial reportQatar medical journal2025

Predictors and outcomes of successful primary nasal intermittent positive pressure ventilation in extremely preterm infants: A retrospective observational study.

Ratheesh Paramban, Jojo Furigay, Sabry Nasr, Jihad Al Shouli, Ashraf Gad

Abstract readClinical Trial
In one paragraph

Trial report in Qatar medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ratheesh ParambanDepartment of Critical Care, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar *Email: agad2@hamad.qa.
Jojo FurigayDepartment of Critical Care, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar *Email: agad2@hamad.qa.
Sabry NasrDepartment of Critical Care, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar *Email: agad2@hamad.qa.
Jihad Al ShouliDepartment of Critical Care, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar *Email: agad2@hamad.qa.
Ashraf GadDepartment of Critical Care, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar *Email: agad2@hamad.qa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to evaluate the effectiveness and short-term outcomes of primary nasal intermittent positive pressure ventilation (NIPPV) in extremely preterm (EP) infants with respiratory distress syndrome (RDS). Methods: A retrospective case-control study was conducted at the Women's Wellness and Research Center in Qatar, from January 2017 to December 2019. Primary NIPPV success was defined as the absence of surfactant administration or mechanical ventilation within the first 72 hours of life. Results: Of 367 infants requiring respiratory support at birth, 69 were managed with primary NIPPV. Among them, 62.3% succeeded (NIPPV-S) and 37.7% failed (NIPPV-F). Birth weights (956 g vs. 937 g) and gestational ages (26.3 weeks vs. 26.2 weeks) were similar between groups. NIPPV-S babies had more vaginal deliveries (48.8% vs. 19.2%, Conclusions: Among EP infants managed with primary NIPPV, success within the first 72 hours was associated with lower initial FiO

Indexed as

continuous positive airway pressureExtremely pretermnasal intermittent positive pressure ventilationneonatesrespiratory distress syndromesurfactant

Identifiers

PMID40969726
PMCPMC12442309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.